Speech-language pathology billing produces a specific cluster of denials that differ from other outpatient specialties in one important way: the codes are per-session rather than units-based, so denial volume concentrates in modifier compliance, medical necessity documentation, and prior authorization gaps rather than in units-counting errors. Four patterns account for the majority of SLP claim denials. Recognizing them as a set makes the audit faster than working each claim one at a time.
The GO modifier and CO-4
Medicare identifies speech-language pathology services using the GO modifier. Without GO on every SLP procedure line, Medicare denies the claim as CO-4 (procedure inconsistent with modifier used, or required modifier missing). The corrected-claim fix is straightforward: resubmit with GO on every line. The real fix is a billing rule that appends GO automatically to all SLP procedure codes before submission. Manual modifier attachment on each line is the single most preventable SLP denial source.
Commercial payers handle this differently. Some follow the Medicare GO convention; others do not require a therapy-type modifier at all; a few use the provider's taxonomy code to identify SLP rather than a modifier. Verify requirements payer by payer rather than assuming GO resolves a CO-4 from a commercial carrier.
Medical necessity documentation and CO-50
CO-50 is the most common unresolved denial in SLP billing. Payers apply it when the clinical record does not establish that skilled speech therapy was necessary rather than monitoring or home practice. The documentation standard parallels physical therapy: a functional deficit, a reason skilled care is required rather than routine maintenance, objective progress toward measurable functional goals, and a treatment plan with a concrete discharge endpoint.
- A dysphagia note that lists techniques used without documenting baseline swallowing function or improvement across sessions gives a payer's utilization reviewer nothing to approve.
- An aphasia note that says "patient worked on naming tasks" without specifying baseline naming accuracy, session performance, and a target functional threshold fails the same review.
- Articulation therapy for a child with a developmental disorder still needs functional outcome measures referenced to age norms, not just "continued with /r/ therapy."
Authorization gaps between evaluation and treatment
A pattern specific to SLP billing: many payers authorize the initial evaluation and ongoing therapy on separate authorization requests. A practice that obtains an evaluation authorization, completes the eval, and then begins treatment under the same auth number is billing treatment sessions without a valid treatment authorization. That produces CO-197 or CO-15 denials on every treatment session.
The fix is procedural. When an evaluation auth is approved, submit the treatment authorization request before the first treatment visit. Many payers require the treatment plan from the evaluation as supporting documentation for the treatment auth, so build the treatment auth request into the workflow that generates the evaluation report rather than treating it as a separate follow-up step.
Fluency programs, AAC (augmentative and alternative communication) device evaluations, and voice therapy often require separate authorization tracks from standard articulation or language therapy. Do not assume one auth number covers all SLP service types for a given patient. Verify the payer's authorization categories at scheduling.
Diagnosis-code specificity and CO-11
CO-11 denials in SLP billing typically trace to ICD-10 unspecified codes where the payer expects a more specific entry. Three combinations produce most of this volume:
- R13.10 (dysphagia, unspecified) used where the chart supports R13.11 (oral phase) or R13.12 (oropharyngeal phase). Some payers cover specific phases and not others, so using the unspecified code can trigger both a CO-11 and a coverage question.
- F80.9 (developmental disorder of speech and language, unspecified) used where F80.0 (phonological disorder), F80.1 (expressive language disorder), or F80.2 (mixed receptive-expressive) is supported by the evaluation. Specificity here can affect whether the service is covered at all, not just whether it is medically necessary.
- R47.89 (other speech disturbances) used for aphasia instead of R47.01 (aphasia). Aphasia codes carry separate coverage rules for some payers that R47.89 does not trigger.
The fix is a corrected claim with the correct ICD-10 code linked to the affected service line. Sort your SLP denials by CARC code 11 and group by ICD-10 to find patterns. A single unspecified code used across many claims from the same coder produces the same CO-11 on every claim, so one correction to the billing template stops all future instances rather than requiring individual claim rework.
Starting the audit
Pull the last 90 days of SLP denials and sort by CARC code. A CO-4 cluster from Medicare almost always resolves with a billing rule for the GO modifier. CO-50 clusters point to documentation templates that are not generating the functional outcome data payers look for. CO-197 clusters point to an authorization workflow that is not distinguishing evaluation authorization from treatment authorization. CO-11 clusters point to a small set of ICD-10 codes used at the wrong level of specificity.
Practices with high dysphagia billing volume should also audit paid claims: compare the ICD-10 specificity on paid versus denied lines to confirm the payer's coverage pattern before assuming every CO-11 is fixable with a corrected claim. Some payers cover specific dysphagia phases and exclude others regardless of documentation quality. Knowing that ahead of the appeal changes whether the right response is a clinical argument or a patient responsibility conversation. The broader framework for finding silent denials and underpayments that never reach a work queue applies here too: check paid lines, not just the denied ones.